BioPhorum announced today that Dan Spacie has joined the company as Chief Executive Officer. Since December 2019, Dan has been immersing himself in the business, reviewing BioPhorum’s strategy, internal organization and plans.  This has given Dan the time to design and create the CEO role, bridging between our past successes and the needs of the business going forward.

Tony White, one of the company’s five founders, said, “We are delighted to welcome Dan to BioPhorum.  He is a key appointment for us. As the collaboration grows in breadth and the ambitions of our clients increase, it is critical that we continue to review and refine our organization to match the evolving needs.  We have felt for some time that the creation of a CEO position has been a necessary next step, helping us simplify reporting lines and accelerate decision-making.  Dan is a natural collaborator, a talented leader, and this combines with his relevant experience to make him ideally placed to support growth and help us continue to deliver for our members over the coming years.”

Dan Spacie has over 30 years’ leadership experience gained from working in biopharmaceuticals, banking and consulting. Fifteen years ago, Dan entered our sector to lead the acquisition and integration of an SME pharmaceutical company into STADA.  Subsequently, he led the development and commercialization of assets across multiple geographies.

Tony went on to say, “The speed with which Dan has understood the needs of our virtual organization and the complexities of facilitating over 80 global best practice and change missions is impressive.  He has already brought clarity of thinking and solutions to bear while in the middle of his first 100 days, filling us with confidence for the future.”

For further information, contact mail@biophorum.com.